Clarified the standard of care statement to specifically say ovarian cancer and moved the sentence earlier in the paragraph along with the reference since it was talking about ovarian cancer, not peritoneal dialysis.
In animals, it is used predominantly in veterinary medicine and animal testing for the administration of systemic drugs and fluids because of the ease of administration compared with other [[parenteral]] methods.{{ref-needed|date=April 2015}}
In humans, the method is widely used to administer [[chemotherapy]] drugs to treat some [[cancer]]s, particularly [[ovarian cancer]]. Fluids are injected intraperitoneally in infants, also used for peritoneal dialysis. Although controversial, that specificintraperitoneal use in ovarian cancer has been recommended as a [[standard of care]].<ref name="pmid18006894">{{cite journal|vauthors=Swart AM, Burdett S, Ledermann J, Mook P, Parmar MK|date=April 2008|title=Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review|url=http://annonc.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18006894|journal=Ann. Oncol.|volume=19|issue=4|pages=688–95|doi=10.1093/annonc/mdm518|pmid=18006894}}</ref> Fluids are injected intraperitoneally in infants, also used for peritoneal dialysis.
|vauthors=Swart AM, Burdett S, Ledermann J, Mook P, Parmar MK | title = Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review
